Services

EATRIS-Finland Services

EATRIS-Finland services have been organized in two main packages which support key needs for academic and commercial customers. Single services can also be obtained from the offered packages.

Package #1:  ATMP MANUFACTURING, VECTOR AND CELL SERVICES

This service platform covers the entire chain from biological starting materials, cells and vectors to manufacturing, cell banking and documentation of ATMP materials. Services included are:

– AAV, adenovirus and lentivirus small and large-scale manufacturing and Lipid nanoparticle-modified/stabilized mRNA microfluidics production (NVVL)

– Virus vector cell banks and master virus seed stocks (NVVL)

– Process development and manufacturing of GMP cell therapy products for pre-clinical and clinical trials (FRCBS, REGEA)

– Provision of cell therapy starting materials (leukapheresis, HLA-typed Cord blood units, buffy coats for research purposes including HLA-selected units and autologous adipose-derived stem cells) (FRCBS,REGEA)

– Cell, vector and tissue banking services (NVVL, REGEA)

– Deep Sequencing services (FIMM)

Package #2:  PET-TRACER DEVELOPMENT, PET-IMAGING, ANTIBODY AND PRECLINICAL SAFETY AND EFFICACY EVALUATION SERVICES

– Translational, pre-clinical and clinical PET tracer development and evaluation of specificity and pharmacokinetic properties using total body PET imaging (PET Center)

– Development, screening and production of high affinity binders (mAbs, Darpins) and recombinant proteins for diagnostics and targeted treatments, and bioaffinity assay development service (Life Technology, VTT)

– Preclinical GLP animal services for the evaluation of general safety, toxicology and efficacy in selected small and large animal models (TDC)